•
SV
SVA
Sinovac Biotech, Ltd
yahoo--
Price Chart
No chart data available
Market Cap
--
Volume
0.00
52W High
--
52W Low
--
Open
--
Prev Close
$6.47
Day Range
-- - --
About Sinovac Biotech, Ltd
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
Latest News
SINOVAC Management Statement Regarding Auditor Resignation
GlobeNewswire Inc.•Apr 22
Respiratory Disease Vaccines Market Research Report 2025: Analysis and Forecast (2020-2030) Featuring GSK, Johnson & Johnson Services, Pfizer, Sanofi, Serum Institute of India, SINOVAC Biotech & More
GlobeNewswire Inc.•Feb 6
$12.5 Bn Influenza Vaccine Market to 2032 by Vaccine Type, Technology, Age Group, Route of Administration, and Region
GlobeNewswire Inc.•Sep 9
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
GlobeNewswire Inc.•Nov 27
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch Systemâ„¢ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
GlobeNewswire Inc.•Oct 27
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
GlobeNewswire Inc.•Oct 11
Sernova Presents Compelling New Data on the Cell Pouch Systemâ„¢ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting
GlobeNewswire Inc.•Sep 29
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
GlobeNewswire Inc.•Sep 14